Jorge Conde

Chief Strategy Officer, Syros Pharmaceuticals, Inc.

Companies

EQRx, Inc.Board member Dec 21, 2021 to Nov 9, 2023¹
Syros Pharmaceuticals, Inc.Chief Strategy Officer Jun 29, 2016 to Jun 29, 2016²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

EQRx, Inc.0 shares³Nov 9, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Nov 9, 2023Returned to company 5,000,000 shares of EQRx, Inc.³
Nov 9, 2023Returned to company 11,433,677 shares of EQRx, Inc.³
Nov 9, 2023Returned to company 19,192,015 shares of EQRx, Inc.³
Nov 9, 2023Returned to company 17,438,465 shares of EQRx, Inc.³
Dec 17, 2021Granted 5,000,000 shares at $10.00 of EQRx, Inc.⁴
Dec 17, 2021Granted 11,433,677 shares of EQRx, Inc.⁴
Dec 17, 2021Granted 19,192,015 shares of EQRx, Inc.⁴
Dec 17, 2021Granted 17,438,465 shares of EQRx, Inc.⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGAREQRx, Inc., Board member
2
SEC EDGARSyros Pharmaceuticals, Inc., Chief Strategy Officer
3
SEC EDGAREQRx, Inc. shares after the filing of Nov 9, 2023
4
SEC EDGARForm 4 filed Dec 21, 2021